Information Library
Go-to-Market - Primary Care
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
Incremental Cost of Otitis Media Among Children in the United States
June 25, 2009
Using a nationally representative data source, the study estimates the medical cost of treating otitis media among children in the US. The costs are estimated at $2 billion in 2005. -
Launching a Successful Brand in a Genericized Market
March 27, 2009
The market for this particular category of muscle relaxants was owned by 10 mg tablets, both branded and generic. Our customer wanted to launch a 5 mg tablet that – contrary to physician and pharmacist preconceptions – was fully as effective as the 10 mg version.
Page 1 of 1 (2 items)